• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

美国医生干细胞培训项目分析——可信度的幻影

An analysis of stem cell training programs for physicians in the US-A mirage of credibility.

作者信息

Ellythy Luqman, Addani Mohamed, Master Zubin

机构信息

Mayo Clinic Alix School of Medicine, Mayo Clinic, Rochester, MN, USA.

Clinical and Translational Science, Mayo Clinic Graduate School of Biomedical Sciences, Mayo Clinic, Rochester, MN, USA.

出版信息

Stem Cell Reports. 2025 Jun 10;20(6):102510. doi: 10.1016/j.stemcr.2025.102510. Epub 2025 May 29.

DOI:10.1016/j.stemcr.2025.102510
PMID:40446797
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12181954/
Abstract

Analyzing stem cell training businesses for United States (US) physicians shows the use of sensationalized marketing language emphasizing profits and growth with many of the instructors affiliated with clinics providing unproven therapies. We argue that many current pedagogical offerings for physicians interested in stem cell interventions are likely to offer questionable training and outline red flags for physicians interested in stem cell therapies.

摘要

对美国医生的干细胞培训业务进行分析后发现，这些业务使用耸人听闻的营销语言，强调利润和增长，而且许多培训讲师都与提供未经证实疗法的诊所有关联。我们认为，目前针对对干细胞干预感兴趣的医生提供的许多教学内容可能会提供有问题的培训，并为对干细胞疗法感兴趣的医生列出警示信号。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1647/12181954/e28e6f89f32d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1647/12181954/e28e6f89f32d/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1647/12181954/e28e6f89f32d/gr1.jpg

相似文献

1
An analysis of stem cell training programs for physicians in the US-A mirage of credibility.美国医生干细胞培训项目分析——可信度的幻影
Stem Cell Reports. 2025 Jun 10;20(6):102510. doi: 10.1016/j.stemcr.2025.102510. Epub 2025 May 29.
2
Providing physicians with feedback on medication adherence for people with chronic diseases taking long-term medication.为正在服用长期药物的慢性病患者的用药依从性向医生提供反馈。
Cochrane Database Syst Rev. 2018 Jan 10;1(1):CD012042. doi: 10.1002/14651858.CD012042.pub2.
3
Stem cell transplantation for induction of remission in medically refractory Crohn's disease.干细胞移植治疗药物难治性克罗恩病诱导缓解。
Cochrane Database Syst Rev. 2022 May 13;5(5):CD013070. doi: 10.1002/14651858.CD013070.pub2.
4
EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.欧洲癌症研究与治疗组织（EORTC）癌症贫血患者促红细胞生成蛋白使用指南：2006年更新版
Eur J Cancer. 2007 Jan;43(2):258-70. doi: 10.1016/j.ejca.2006.10.014. Epub 2006 Dec 19.
5
Stem cell injections for osteoarthritis of the knee.用于膝关节骨关节炎的干细胞注射
Cochrane Database Syst Rev. 2025 Apr 2;4(4):CD013342. doi: 10.1002/14651858.CD013342.pub2.
6
Mobility training for increasing mobility and functioning in older people with frailty.衰弱老年人的活动能力训练可提高其活动能力和功能。
Cochrane Database Syst Rev. 2022 Jun 30;6(6):CD010494. doi: 10.1002/14651858.CD010494.pub2.
7
Shared decision-making for people with asthma.哮喘患者的共同决策
Cochrane Database Syst Rev. 2017 Oct 3;10(10):CD012330. doi: 10.1002/14651858.CD012330.pub2.
8
Interventions for preventing oral mucositis in patients with cancer receiving treatment: cytokines and growth factors.癌症患者接受治疗期间预防口腔黏膜炎的干预措施：细胞因子和生长因子
Cochrane Database Syst Rev. 2017 Nov 28;11(11):CD011990. doi: 10.1002/14651858.CD011990.pub2.
9
Interventions for preventing and reducing the use of physical restraints of older people in general hospital settings.预防和减少一般医院环境中老年人身体约束使用的干预措施。
Cochrane Database Syst Rev. 2022 Aug 25;8(8):CD012476. doi: 10.1002/14651858.CD012476.pub2.
10
Population-based interventions for reducing sexually transmitted infections, including HIV infection.基于人群的减少性传播感染（包括艾滋病毒感染）的干预措施。
Cochrane Database Syst Rev. 2004(2):CD001220. doi: 10.1002/14651858.CD001220.pub2.

本文引用的文献

1
International Society for Cell & Gene Therapy Position Paper: Key considerations to support evidence-based cell and gene therapies and oppose marketing of unproven products.国际细胞与基因治疗学会立场文件：支持基于证据的细胞和基因治疗的关键考虑因素，反对未经证实产品的营销。
Cytotherapy. 2023 Sep;25(9):920-929. doi: 10.1016/j.jcyt.2023.03.002.
2
CME: Is it Meeting the Mark?继续医学教育：它达到标准了吗？
Am J Med. 2023 Jul;136(7):618-619. doi: 10.1016/j.amjmed.2023.02.010. Epub 2023 Mar 9.
3
The American stem cell sell in 2021: U.S. businesses selling unlicensed and unproven stem cell interventions.
2021 年美国的干细胞买卖：美国企业销售未经许可和未经证实的干细胞干预措施。
Cell Stem Cell. 2021 Nov 4;28(11):1891-1895. doi: 10.1016/j.stem.2021.10.008.
4
ISSCR Guidelines for Stem Cell Research and Clinical Translation: The 2021 update.国际干细胞研究学会干细胞研究与临床转化指南：2021 年更新版。
Stem Cell Reports. 2021 Jun 8;16(6):1398-1408. doi: 10.1016/j.stemcr.2021.05.012. Epub 2021 May 27.
5
Academic physician specialists' views toward the unproven stem cell intervention industry: areas of common ground and divergence.学术医师专家对未经证实的干细胞干预产业的看法：共识和分歧领域。
Cytotherapy. 2021 Apr;23(4):348-356. doi: 10.1016/j.jcyt.2020.12.011. Epub 2021 Feb 6.
6
Characteristics and Scope of Training of Clinicians Participating in the US Direct-to-Consumer Marketplace for Unproven Stem Cell Interventions.参与美国未经证实的干细胞干预直接面向消费者市场的临床医生的特点和培训范围。
JAMA. 2019 Jun 25;321(24):2463-2464. doi: 10.1001/jama.2019.5837.
7
Regenerative medicine curriculum for next-generation physicians.面向下一代医生的再生医学课程。
NPJ Regen Med. 2019 Feb 7;4:3. doi: 10.1038/s41536-019-0065-8. eCollection 2019.
8
Marketing of unproven stem cell-based interventions: A call to action.未经证实的基于干细胞的干预措施的营销：行动呼吁。
Sci Transl Med. 2017 Jul 5;9(397). doi: 10.1126/scitranslmed.aag0426.
9
Call for fellowship programs in stem cell-based regenerative and cellular medicine: new stem cell training is essential for physicians.呼吁开展基于干细胞的再生和细胞医学研究员计划：新的干细胞培训对于医生来说至关重要。
Regen Med. 2013 Mar;8(2):223-5. doi: 10.2217/rme.13.1.